307 related articles for article (PubMed ID: 25925209)
41. microRNA-320a inhibits tumor invasion by targeting neuropilin 1 and is associated with liver metastasis in colorectal cancer.
Zhang Y; He X; Liu Y; Ye Y; Zhang H; He P; Zhang Q; Dong L; Liu Y; Dong J
Oncol Rep; 2012 Mar; 27(3):685-94. PubMed ID: 22134529
[TBL] [Abstract][Full Text] [Related]
42. Circulating miR-199a-3p as a novel serum biomarker for colorectal cancer.
Nonaka R; Nishimura J; Kagawa Y; Osawa H; Hasegawa J; Murata K; Okamura S; Ota H; Uemura M; Hata T; Takemasa I; Mizushima T; Okuzaki D; Yamamoto H; Doki Y; Mori M
Oncol Rep; 2014 Dec; 32(6):2354-8. PubMed ID: 25269744
[TBL] [Abstract][Full Text] [Related]
43. MicroRNA-324 in Human Cancer: miR-324-5p and miR-324-3p Have Distinct Biological Functions in Human Cancer.
Kuo WT; Yu SY; Li SC; Lam HC; Chang HT; Chen WS; Yeh CY; Hung SF; Liu TC; Wu T; Yu CC; Tsai KW
Anticancer Res; 2016 Oct; 36(10):5189-5196. PubMed ID: 27798879
[TBL] [Abstract][Full Text] [Related]
44. miRNA profiling in colorectal cancer highlights miR-1 involvement in MET-dependent proliferation.
Reid JF; Sokolova V; Zoni E; Lampis A; Pizzamiglio S; Bertan C; Zanutto S; Perrone F; Camerini T; Gallino G; Verderio P; Leo E; Pilotti S; Gariboldi M; Pierotti MA
Mol Cancer Res; 2012 Apr; 10(4):504-15. PubMed ID: 22343615
[TBL] [Abstract][Full Text] [Related]
45. Serum miR-1301-3p, miR-335-5p, miR-28-5p, and their target B7-H3 may serve as novel biomarkers for colorectal cancer.
Wang L; Zhao Y; Xu M; Zhou F; Yan J
J BUON; 2019; 24(3):1120-1127. PubMed ID: 31424670
[TBL] [Abstract][Full Text] [Related]
46. Post-transcriptional regulation of the tumor suppressor miR-139-5p and a network of miR-139-5p-mediated mRNA interactions in colorectal cancer.
Shen K; Mao R; Ma L; Li Y; Qiu Y; Cui D; Le V; Yin P; Ni L; Liu J
FEBS J; 2014 Aug; 281(16):3609-24. PubMed ID: 24942287
[TBL] [Abstract][Full Text] [Related]
47. Novel Molecular Characterization of Colorectal Primary Tumors Based on miRNAs.
Moreno EC; Pascual A; Prieto-Cuadra D; Laza VF; Molina-Cerrillo J; Ramos-Muñoz ME; Rodríguez-Serrano EM; Soto JL; Carrato A; García-Bermejo ML; Guillén-Ponce C
Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30862091
[TBL] [Abstract][Full Text] [Related]
48. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening.
Ng EK; Chong WW; Jin H; Lam EK; Shin VY; Yu J; Poon TC; Ng SS; Sung JJ
Gut; 2009 Oct; 58(10):1375-81. PubMed ID: 19201770
[TBL] [Abstract][Full Text] [Related]
49. [Inheritable changes in miRNAs expression in HeLa cells after X-ray and mitomycin C treatment].
Tarasov VA; Matishov DG; Shin EF; Boĭko NV; Timoshkina NN; Makhotkin MA; Lomonosov AM; Kirpiĭ AA
Genetika; 2014 Aug; 50(8):909-17. PubMed ID: 25731020
[TBL] [Abstract][Full Text] [Related]
50. MiRNAs as molecular biomarkers in stage II egyptian colorectal cancer patients.
Bahnassy AA; Salem SE; El-Sayed M; Khorshid O; Abdellateif MS; Youssef AS; Mohanad M; Hussein M; Zekri AN; Ali NM
Exp Mol Pathol; 2018 Dec; 105(3):260-271. PubMed ID: 30213464
[TBL] [Abstract][Full Text] [Related]
51. miRNA profiling identifies candidate mirnas for bladder cancer diagnosis and clinical outcome.
Ratert N; Meyer HA; Jung M; Lioudmer P; Mollenkopf HJ; Wagner I; Miller K; Kilic E; Erbersdobler A; Weikert S; Jung K
J Mol Diagn; 2013 Sep; 15(5):695-705. PubMed ID: 23945108
[TBL] [Abstract][Full Text] [Related]
52. Housekeeping genes for studies of plasma microRNA: A need for more precise standardization.
Rice J; Roberts H; Rai SN; Galandiuk S
Surgery; 2015 Nov; 158(5):1345-51. PubMed ID: 26094174
[TBL] [Abstract][Full Text] [Related]
53. Systematic analysis of key miRNAs and related signaling pathways in colorectal tumorigenesis.
Yin Y; Song M; Gu B; Qi X; Hu Y; Feng Y; Liu H; Zhou L; Bian Z; Zhang J; Zuo X; Huang Z
Gene; 2016 Mar; 578(2):177-84. PubMed ID: 26692142
[TBL] [Abstract][Full Text] [Related]
54. The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.
Kong Y; Bai PS; Sun H; Nan KJ; Chen NZ; Qi XG
Int J Biochem Cell Biol; 2012 Dec; 44(12):2321-32. PubMed ID: 22903020
[TBL] [Abstract][Full Text] [Related]
55. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of esophageal squamous cell carcinoma.
Yang M; Liu R; Sheng J; Liao J; Wang Y; Pan E; Guo W; Pu Y; Yin L
Oncol Rep; 2013 Jan; 29(1):169-76. PubMed ID: 23124769
[TBL] [Abstract][Full Text] [Related]
56. Exploration of inhibitory mechanisms of curcumin in lung cancer metastasis using a miRNA- transcription factor-target gene network.
Jiao DM; Yan L; Wang LS; Hu HZ; Tang XL; Chen J; Wang J; Li Y; Chen QY
PLoS One; 2017; 12(2):e0172470. PubMed ID: 28231299
[TBL] [Abstract][Full Text] [Related]
57. Deep sequencing of RNA from three different extracellular vesicle (EV) subtypes released from the human LIM1863 colon cancer cell line uncovers distinct miRNA-enrichment signatures.
Ji H; Chen M; Greening DW; He W; Rai A; Zhang W; Simpson RJ
PLoS One; 2014; 9(10):e110314. PubMed ID: 25330373
[TBL] [Abstract][Full Text] [Related]
58. Absolute quantification of cell-free microRNAs in cancer patients.
Ferracin M; Lupini L; Salamon I; Saccenti E; Zanzi MV; Rocchi A; Da Ros L; Zagatti B; Musa G; Bassi C; Mangolini A; Cavallesco G; Frassoldati A; Volpato S; Carcoforo P; Hollingsworth AB; Negrini M
Oncotarget; 2015 Jun; 6(16):14545-55. PubMed ID: 26036630
[TBL] [Abstract][Full Text] [Related]
59. [Effect of microRNA on proliferation caused by mutant HBx in human hepatocytes].
Fu XY; Tan DM; Hou ZH; Hu ZL; Liu GZ; Ouyang Y; Liu F
Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):598-604. PubMed ID: 23207154
[TBL] [Abstract][Full Text] [Related]
60. The use of circulating microRNAs as diagnostic biomarkers in colorectal cancer.
Clancy C; Joyce MR; Kerin MJ
Cancer Biomark; 2015; 15(2):103-13. PubMed ID: 25547322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
